Intraocular pressure lowering effect of latanoprost for glaucomatous patients with trabeculectomy

Intraocular pressure lowering effect of latanoprost for glaucomatous patients with trabeculectomy - Latanoprost after trabeculectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000893

Enrollment

Registered

2007-11-15

Start date

2007-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with open-angle glaucoma after trabeculectomy

Interventions

0.005% latanoprost, once daily for 6 months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with open-angle glaucoma. Intraocular pressure level of 15 mmHg or higher. Within 12 months after trabeculectomy.

Exclusion criteria

Exclusion criteria: Patients with contraindication for the use of latanoprost. Patients with incapable measurement of intraocular pressure due to corneal diseases. Patients with intraocular inflammation.

Design outcomes

Primary

Measure	Time frame
Intraocular pressure	—

Countries

Japan

Contacts

Public ContactMasaru Inatani

Kumamoto University Graduate School of Medical Sciences Department of Ophthalmology and Visual Science

096-373-5247

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026